158 results on '"HYPOGLYCEMIC agents"'
Search Results
2. A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY)
3. Effect of Bariatric Surgery Versus Medical Therapy on Metabolic Syndrome (EBSMTMS)
4. Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes
5. The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease (ESS-AKD)
6. 'How Awareness and Subjectivity Modulate the Placebo Effect' (AS-m-P)
7. Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction
8. Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation (E-VAL)
9. The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II (RAID-II)
10. The Impact of Glucotoxicity on Gastric Emptying in Chinese Patients With Newly Diagnosed Type 2 Diabetes
11. A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes (AWARD-JPN)
12. Effects of a Health Intervention on Hypoglycemic Coping : a Pilot Study
13. Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
14. To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin
15. Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS) (PCOS)
16. Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls
17. Improving Glycaemic Control in Patients With Type 2 Diabetes Mellitus Through Peer Support Instant Messaging (DiabPeerS)
18. Mechanisms of Post-Bariatric Hypoglycemia
19. Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
20. Benefits of Trimetazidine in MAFLD Pateints (MAFLD)
21. Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI (NSCLC)
22. The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy
23. Effect of Empagliflozin on Body Composition and Ketones
24. The Functional Neuroanatomy of the Human Physiological Stress Response (Hypo fMRI)
25. Regimen Switch After Intensive Insulin Therapy
26. The Different Response of Endocrine Hormones to Hypoglycemia in Patients With Type 1 or Type 2 Diabetes
27. Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes
28. Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial (ELUCIDATE)
29. The HypoVoice Study (HypoVoice)
30. Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy (ANGIOSAFE2)
31. The HEADWIND Study - Part 4
32. Dapagliflozin Effect in Cognitive Impairment in Stroke Trial (DECIST)
33. Hypoglycemia and Autonomic Nervous System Function- B2 (HypoANS-B2)
34. Hypoglycemia and Cardiac Arrhythmias in Type 1 Diabetes (Hypo-Heart-1)
35. A Clinical Study on the Effect of Hypoglycemic Drugs on the Prognosis of Spinal Surgery in Diabetic Patients
36. Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus (VETA)
37. Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
38. The HEADWIND Study - Part 3
39. Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
40. Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy (EDITION AP)
41. TEsting METformin Against Cognitive Decline in HD
42. Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period (LixiLan-G)
43. Association Between Natural Hypoglycemic Foods and Blood Sugar Level: A Pilot Study
44. Endotherapy for Painless Chronic Pancreatitis (EACH)
45. A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
46. Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease (EFFORT)
47. Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus (Sulfa-Zero)
48. Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions (SAFARY)
49. Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study
50. The HEADWIND Study - Part 2 (HEADWIND)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.